Heart Disease Clinical Trials in Cleveland

Showing 121-140 of 521 trials

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

NCT03900026

The purpose of this study is to determine if evolocumab added to regular statin therapy improves vein graft patency after coronary artery bypass graft (CABG) surgery.

Coronary Artery Bypass Graft SurgeryAtherosclerosisVein Occlusion

Unity Health Toronto782 participantsStarted May 2019

San Francisco, California, United States • Jacksonville, Florida, United States • Portland, Maine, United States +19 more locations

RECRUITINGPhase 2< 1 mile

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298

This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart failure. There will be 2 cohorts in this study: Cohort 1: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) of ≤ 40%. Cohort 2: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) \> 40% and ≤ 65%.

Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction

Salubris Biotherapeutics Inc282 participantsStarted Mar 2024

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +59 more locations

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Study of JK07 in Patients With Chronic Heart Failure

Heart Disease Trials in Other Cities

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Hemodynamic-GUIDEd Management of Heart Failure

Optisure Lead Post Approval Study

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

Long Term Follow Up for CTSN Mitral Valve Repair Studies

Project 3: ACHIEVE- CHD

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Abbott Vascular Medical Device Registry

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

Global Utilization And Registry Database for Improved heArt preservatioN

STICH3C Cardiac Magnetic Resonance Observational Study

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

RADIQAL Study (Radiation Dose and Image Quality Trial)

Other Conditions in Cleveland